Foundation Fighting Blindness Retinal Degeneration Fund

Director, See Remarks, Opus Genetics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$18.8M

Companies

Latest trade

Sep 30, 2026

Companies

Opus Genetics, Inc.Director, See Remarks −$18.8M

Trades

IRD Sold 556,000 shares at $4.96 $2.8M Sep 30

IRD Sold 1,700,000 shares at $4.35 $7.4M May 18

IRD Sold 4,000,000 shares at $2.15 $8.6M Dec 9

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.